HeartSciences Inc. financial data

Symbol
HSCS, HSCSW on Nasdaq
Location
Southlake, TX
Fiscal year end
30 April
Latest financial report
10-Q - Q3 2025 - 15 Dec 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 118% % -66%
Quick Ratio 22% % -31%
Debt-to-equity 140% % 250%
Return On Equity -388% % -230%
Return On Assets -162% % -92%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3,178,207 shares 224%
Common Stock, Shares, Outstanding 3,071,135 shares 224%
Entity Public Float $5,400,000 USD -74%
Common Stock, Value, Issued $3,071 USD 224%
Weighted Average Number of Shares Outstanding, Basic 2,780,496 shares 203%
Weighted Average Number of Shares Outstanding, Diluted 2,780,496 shares 203%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $2,419 USD
Cost of Revenue $1,008 USD
Research and Development Expense $3,686,441 USD -7.4%
Operating Income (Loss) $8,239,393 USD -10%
Nonoperating Income (Expense) $796,992 USD -402%
Net Income (Loss) Attributable to Parent $9,036,385 USD -19%
Earnings Per Share, Basic -6.86 USD/shares -225%
Earnings Per Share, Diluted -6.86 USD/shares -225%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,951,103 USD -52%
Accounts Receivable, after Allowance for Credit Loss, Current $4,350 USD
Inventory, Net $657,285 USD 0.67%
Other Assets, Current $257,959 USD 539%
Assets, Current $3,793,488 USD -33%
Property, Plant and Equipment, Net $52,986 USD -31%
Operating Lease, Right-of-Use Asset $321,633 USD -23%
Assets $5,996,117 USD -23%
Accounts Payable, Current $317,390 USD 15%
Accrued Liabilities, Current $311,184 USD -16%
Liabilities, Current $1,566,384 USD -53%
Operating Lease, Liability, Noncurrent $247,263 USD -34%
Liabilities $1,813,647 USD -52%
Retained Earnings (Accumulated Deficit) $80,533,398 USD -13%
Stockholders' Equity Attributable to Parent $4,182,470 USD 4.1%
Liabilities and Equity $5,996,117 USD -23%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,953,367 USD 3.2%
Net Cash Provided by (Used in) Financing Activities $3,648,314 USD 561%
Net Cash Provided by (Used in) Investing Activities $814 USD 2.3%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 3,071,135 shares 224%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,694,133 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,951,103 USD -52%
Deferred Tax Assets, Valuation Allowance $15,461,664 USD 14%
Operating Lease, Liability $376,240 USD -23%
Depreciation $7,111 USD -40%
Lessee, Operating Lease, Liability, to be Paid $440,121 USD -27%
Property, Plant and Equipment, Gross $604,461 USD 0.59%
Operating Lease, Liability, Current $128,977 USD 17%
Lessee, Operating Lease, Liability, to be Paid, Year Two $173,558 USD 2.5%
Lessee, Operating Lease, Liability, to be Paid, Year One $169,307 USD 2.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $63,881 USD -45%
Lessee, Operating Lease, Liability, to be Paid, Year Three $14,493 USD -92%
Deferred Tax Assets, Operating Loss Carryforwards $12,234,806 USD 4.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $14,493 USD -92%
Operating Lease, Payments $13,129 USD 0%
Additional Paid in Capital $84,711,837 USD 12%
Interest Expense $354,080 USD 46%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%